Cargando…
Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics
It is time for those working on oncolytic viruses to take stock of the status of the field. We now have at our disposal an array of potential therapeutic agents, and are beginning to conduct early-phase clinical trials in patients with relapsed/metastatic cancers. By drawing on lessons learned durin...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915505/ https://www.ncbi.nlm.nih.gov/pubmed/20223697 http://dx.doi.org/10.1016/j.cytogfr.2010.02.006 |